- Home
- UPB vs GLRE Comparison
UPB vs GLRE Comparison
Compare UPB & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- GLRE
- Stock Information
- Founded
- UPB 2021
- GLRE 2004
- Country
- UPB United States
- GLRE Cayman Islands
- Employees
- UPB N/A
- GLRE N/A
- Industry
- UPB
- GLRE Property-Casualty Insurers
- Sector
- UPB
- GLRE Finance
- Exchange
- UPB NYSE
- GLRE Nasdaq
- Market Cap
- UPB 521.3M
- GLRE 466.5M
- IPO Year
- UPB 2024
- GLRE 2007
- Fundamental
- Price
- UPB $10.84
- GLRE $14.44
- Analyst Decision
- UPB Strong Buy
- GLRE
- Analyst Count
- UPB 4
- GLRE 0
- Target Price
- UPB $56.50
- GLRE N/A
- AVG Volume (30 Days)
- UPB 405.0K
- GLRE 89.9K
- Earning Date
- UPB 05-06-2025
- GLRE 05-07-2025
- Dividend Yield
- UPB N/A
- GLRE N/A
- EPS Growth
- UPB N/A
- GLRE N/A
- EPS
- UPB N/A
- GLRE 1.32
- Revenue
- UPB $2,296,000.00
- GLRE $717,617,000.00
- Revenue This Year
- UPB N/A
- GLRE N/A
- Revenue Next Year
- UPB N/A
- GLRE N/A
- P/E Ratio
- UPB N/A
- GLRE $11.01
- Revenue Growth
- UPB N/A
- GLRE 2.79
- 52 Week Low
- UPB $5.14
- GLRE $11.95
- 52 Week High
- UPB $29.46
- GLRE $15.82
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- GLRE 70.16
- Support Level
- UPB N/A
- GLRE $13.33
- Resistance Level
- UPB N/A
- GLRE $14.60
- Average True Range (ATR)
- UPB 0.00
- GLRE 0.39
- MACD
- UPB 0.00
- GLRE 0.10
- Stochastic Oscillator
- UPB 0.00
- GLRE 86.36
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.